65,437 trials
Healthy
Primary: Rate of Iron Excretion. — 1.07; 1.69; 1.08 milligrams per day — p=< 0.05
Crohn's Disease
Primary: Clinical Remission — 17.8; 19.2 percentage of participants — p=.858
Healthy
Primary: Frequency Distribution of Skin Irritation Scores — 39; 10; 3; 0 Scores on a scale
Hyperglycemia · Diabetes
Primary: Percentage of Blood Glucose Values Between 80 - 140 — 43; 35; 48 percentage of blood glucose values
Bipolar Disorder
Primary: Young Mania Rating Scale (YMRS) Total Score Change From Baseline — -3.8; -4.0; -6.3; -6.1 score on scale
Irritable Colon
Primary: Left Colon Mucosal Blood Flow (MBF) — 125.6; 117.5; 130.7; 121.6 ml per minute per 100 grams of tissue — p=0.131
Chronic Obstructive Pulmonary Disease · Bronchitis · Emphysema
Primary: Time-normalized Area Under the Change From Study Baseline Curve for Forced Expiratory Volume in One Second (FEV1) Over 24 Hours (nAUC0-24B) — 0.104; 0.080; 0.221 Liters…
Prostatic Hyperplasia
Primary: Change From Baseline in International Prostate Symptom Score (IPSS) at Week 52 — -3.6; -5.5 score on a scale — p=0.003
Fabry Disease
Primary: Globotriaosylceramide (GL-3) Clearance in Kidney Interstitial Capillary Endothelium — 3; 21; 18; 17 Participants
Hepatitis B
Primary: The Number of Seroresponders to the Modified Process Hepatitis B Vaccine and RECOMBIVAX HB™ (Currently Licensed Vaccine) — 115; 100 Participants
Type 2 Diabetes Mellitus
Primary: Change From Baseline in Hemoglobin A1c (HbA1c ) at Week 12 — -0.4; 0.4 Percent — p=<0.001
Hepatitis B
Primary: Number of Subjects Seroprotected for Anti-hepatitis B Surface Antigen (Anti-HBs) Antibody. — 233; 111 Subjects
Chronic Constipation
Primary: Intestinal Transit Time — 42.3; 15.66 hours — p=<0.001
Prostate Cancer
Primary: Number of Patients With Testosterone <=0.5 Nanograms/Milliliter From Day 28 to Day 364 — 17; 21; 26; 27 participants
Prostate Cancer
Primary: Time From Dosing Until Testosterone Levels >0.5 ng/mL — 84; 63; 70; 140 days — p=0.0000586